PARISI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 516
EU - Europa 250
AS - Asia 89
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 860
Nazione #
US - Stati Uniti d'America 514
IE - Irlanda 129
SG - Singapore 55
DE - Germania 35
IT - Italia 33
CN - Cina 23
CZ - Repubblica Ceca 17
UA - Ucraina 14
FI - Finlandia 10
TR - Turchia 5
GB - Regno Unito 4
AU - Australia 3
BE - Belgio 3
CA - Canada 2
EU - Europa 2
SE - Svezia 2
VN - Vietnam 2
CY - Cipro 1
ES - Italia 1
ID - Indonesia 1
JP - Giappone 1
KR - Corea 1
RO - Romania 1
RS - Serbia 1
Totale 860
Città #
Chandler 150
Dublin 129
Jacksonville 64
Ashburn 54
Singapore 46
Boardman 42
New York 24
Munich 20
Brno 17
Princeton 16
Lawrence 15
Ann Arbor 11
Wilmington 11
Helsinki 10
L'aquila 7
Los Angeles 6
Dallas 5
L’Aquila 5
Milan 5
Beijing 4
Bremen 4
Des Moines 4
Izmir 4
San Mateo 4
Brussels 3
San Francisco 3
Dong Ket 2
Kitzingen 2
Nanchang 2
Rome 2
Ancona 1
Berlin 1
Birmingham 1
Canberra 1
Edinburgh 1
Fort Worth 1
Frankfurt am Main 1
Hamburg 1
Huizhou 1
Istanbul 1
Jinan 1
Lanciano 1
Nicosia 1
Ningbo 1
Norwalk 1
Prineville 1
Quzhou 1
Seoul 1
Shenyang 1
Springfield 1
Surabaya 1
Sydney 1
Teramo 1
Tianjin 1
Tokyo 1
Toronto 1
Wuhan 1
Totale 698
Nome #
Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A "snapshot" from clinical practice 75
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome 64
The PERSONS score: A new tool for cancer patients' symptom assessment in simultaneous care and home care settings 63
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 58
Expression of pro-angiogenic factors as potential biomarkers in experimental models of colon cancer 57
Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series 54
Evaluation of prognostic factors for survival in transverse colon cancer 54
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 54
A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy 51
Multimodality treatment in metastatic gastric cancer: From past to next future 49
Timed-flat infusion (TFI) 5-fluorouracil with irinotecan and oxaliplatin in pancreatic adenocarcinomas: A single institution experience with FIr/FOx regimen 48
A case of segmental hepatic necrosis complicating oxaliplatin and capecitabine chemotherapy: A case report and review of the literature 45
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study 43
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status. 39
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference 39
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 36
Palliative sedation at home: A medical act practicable everywhere 31
The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients 14
Medium to long-term effects of the COVID-19 pandemic on colorectal cancer diagnosis and management in Italy: preliminary findings from an updated analysis of the real-world multicenter COVID-DELAY study 13
Totale 887
Categoria #
all - tutte 5.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202043 0 0 0 0 0 6 10 1 7 1 0 18
2020/202195 4 11 0 10 13 1 11 4 20 1 17 3
2021/202259 0 0 1 0 2 1 0 5 6 1 6 37
2022/2023379 17 30 3 54 22 40 0 30 164 0 16 3
2023/2024166 6 4 10 6 10 41 3 35 0 6 8 37
2024/2025127 13 10 48 43 13 0 0 0 0 0 0 0
Totale 887